São Paulo, Brazil

Leticia Khater Covesi

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Leticia Khater Covesi: Innovator in Pharmaceutical Dosage Forms

Introduction

Leticia Khater Covesi is a prominent inventor based in São Paulo, Brazil. She has made significant contributions to the field of pharmaceuticals, particularly in the development of dosage forms for treating inflammatory conditions. With a total of two patents to her name, her work is recognized for its innovative approach to medication delivery.

Latest Patents

Leticia's latest patents focus on dosage forms containing fluticasone propionate for the treatment of inflammatory conditions of the esophagus. The inventions describe novel and improved dosage forms that enhance the effectiveness of fluticasone propionate in addressing inflammation-related issues in the esophagus. These advancements are crucial for improving patient outcomes in the treatment of such conditions.

Career Highlights

Leticia is currently associated with Ems S.A., a company known for its commitment to pharmaceutical innovation. Her role at Ems S.A. allows her to leverage her expertise in developing effective treatment options for patients. Her contributions to the field have been instrumental in advancing pharmaceutical science.

Collaborations

Leticia has collaborated with notable professionals in her field, including Giancarlo Santus and Luca Donadoni. These collaborations have fostered a productive environment for innovation and have led to the successful development of her patented technologies.

Conclusion

Leticia Khater Covesi stands out as a dedicated inventor in the pharmaceutical industry. Her innovative work on dosage forms for treating inflammatory conditions showcases her commitment to improving healthcare solutions. Her contributions are paving the way for advancements in medication delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…